FDA Investigator Courtney A Gilbert
Courtney A Gilbert has inspections in 5 countries as of 11 Oct 2023. Courtney A Gilbert has collaborated with a combinined 2758 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
225
Last Inspection Date:
11 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Australia,
Denmark,
Germany
Co-Investigator(s):
A Williams,
Abraham M Maekele,
Adam M Derr,
Albert A Salvador,
Alec D Fabus,
Amy H Ruble,
Amy Kim,
Ana Delp Cintron,
Ana P Barido,
Anabel Veiga,
Andrea Dcharles Julien,
Andrew C Frederick,
Andrew J Mcguffin,
Angela E Glenn,
Ashley B Jelonek,
Barbara T Carmichael,
Betsy C Galliher,
Bill Tacket, Jr,
Bonita S Chester,
Brandi L Garbutt,
Brant M Schroeder,
Bruce Quijano,
CDR Ileana Barreto Pettit,
CDR Sean T Creighton,
Charles D Boison,
Charles S Watson,
Cheryl A Clausen,
Christie A Soto,
Christopher T Smith,
Chyla T Hunter,
Clara E Santiago,
Colleen M Aspinwall,
Courtney A Hunt,
Courtney Hunt,
Craig A Garmendia,
Danielle S Pearson,
David P King,
Delkis J Caycedo,
Devaughn Edwards,
Diana L Kelsch,
Diane Hall,
Dianiris C Ayala,
Dillard H Woody, Jr,
Dionne D Arline,
Donald J Mee,
Dusty F Snoeberg,
Edward A Brunt,
Edwards,
Edwin J Gorney,
Ernest L Levins,
Ethan P Stegman,
Gary E Coleman, Jr, REHS,
Gene R Gunn,
German Rivera,
Gina C Chen,
Gina Eng,
Glenn S Quintanilla,
Harry R Bringger, Jr,
Holly M Scott,
Howard A Webley,
Hunt,
Ivan E Reyes,
Jacqueline E Manjone,
James To Neal,
Jamie I Espinosa,
Jana L Caylor,
Jason D Abel,
Jason D Tenney,
Jason P Aun,
Jennifer A Robinson,
Jennifer L Huntington,
Jennifer Lalama,
Jessica L Pressley,
Joanne E King,
Jolanna A Norton,
Jontae D Sanders,
Jose R Rodriguez,
Karen L Anderson,
Karl D Hezel,
Kathleen D Culver,
Keith A Schwartz,
Kelly I Anderson,
Kenneth L Smalls,
LCDR Michael H Tollon,
LCDR Randall L Morris,
Leo J Lagrotte,
Leon L Crawley,
Leroy Terrelonge,
Leslie A Cartmill,
Leyden Guerrero,
Linda K Matheny,
Lindsay R Hatch,
Lindsay R Mundy,
LT Daveta L Bailey,
LT Kimberly M Hull,
LT Prince D Brown,
LT Tamara J Henderson,
Lura D Baquero,
Lura D Kelly,
Luz I Collado,
Madelyn Renteria,
Marc Balzarini,
Mary F Bodick,
Matthew B Thomaston,
Melanie G Warzala,
Melanie W Pishnery,
Melissa J Hill,
Mendoza,
Meredith M Cobb,
Michelle D Haamid,
Michelle S Dunaway,
Mizanne E Lewis,
Mpris Inspector,
Munoz,
Nancy L Meade,
Nicole E Knowlton,
Nigel L Hirth,
Nisha C Patel,
Noreen Muniz,
Norton,
Ormond,
Paul A Licata,
Paul H Dakin,
Paul L Figarole, Jr,
Rachel A Peters,
Randy L Clarida,
Raymond A Lyn, Jr,
Reynolds,
Richard J Bashay,
Richard K Vogel,
Ronan F King,
Ronnie E Jackson,
Saleem A Akhtar,
Sally Gopaul,
Salvatore N Randazzo,
Samantha J Pinizzotto, D V M,
Saundrea A Munroe,
Scott T Ballard,
Sergio E Delgado,
Shari H Shambaugh,
Sharon Giamberini,
Shavon L Square,
Sherbert Samuels,
Sherbet L Samuels,
Sheri L Stephenson,
Stacey F Rivette,
State Agency,
Stephanie C Milan,
Stephanie D Crockett,
Susan M Corrales,
Susan M Turcovski,
Teresa I Navas,
Teresa M Hillebrandt,
Thai D Truong,
Thomaston,
Traci M Armand,
Twana R Chandler,
Valerie J Grecek Trinh,
Veronica Fuentes, MS,
Virginia L Meeks,
Woody
Courtney A Gilbert's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| July, 2009 | FDA 483 | DOH CENTRAL PHARMACY - Form 483, 2009-07-30 |
| September, 2002 | EIR | Southeast Tissue Alliance, Inc. - EIR, 2002-09-17 |
| October, 2001 | EIR | Rexall Sundown Inc. - EIR, 2001-10-09 |
| September, 2002 | EIR | Regenerative Biologics, Inc. - EIR, 2002-09-16 |
| July, 2002 | FDA 483 Response | Pegasus Laboratories, Inc. - Form 483R, 2002-08-06 |
| November, 2002 | FDA 483 | Gulf Medical Services - Form 483, 2002-11-14 |
| June, 2008 | EIR | Pegasus Laboratories, Inc. - EIR, 2008-06-19 |
| July, 2002 | FDA 483 | Pegasus Laboratories, Inc. - Form 483, 2002-07-23 |
| October, 2002 | FDA 483 | Deuteronomy Management Services Inc. dba ValuMed - Form 483, 2002-10-11 |
| January, 2001 | FDA 483 | Tend Skin International, Inc. - Form 483, 2001-01-23 |
| March, 2003 | FDA 483 | OneBlood, Inc. - Form 483, 2003-03-14 |
| September, 2002 | EIR | Regenerative Biologics, Inc. - EIR, 2002-09-17 |
| July, 2001 | EIR | Tend Skin International, Inc. - EIR, 2001-07-05 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more